Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for MEI Pharma, Inc. (MEIP)

« Back to company index

MEIP Chatter Timeline

Stock Ticker for MEIP

Most Active Tweeters for MEIP

UserTweets
@AmericanBanking 4
@MrHypeMind 3
@StockWatchHQ 2
@dispatchtribune 2
@dailypoliticaln 2

Recent Tweets for MEIP

newswelldone @newswelldone
$MEIP: MEI Pharma: Time To Reload At Key Support Level: https://t.co/N3LpQ49BT5
June 16th 2019, 8:06am
OLEGEFF @OLEGEFF
$MEIP - MEI Pharma: Time To Reload At Key Support Level https://t.co/yiPNS1iJMt
June 16th 2019, 8:06am
SeekingAlpha @SeekingAlpha
$MEIP - MEI Pharma: Time To Reload At Key Support Level https://t.co/Sk2BqpoBwr
June 16th 2019, 8:06am
dispatchtribune @dispatchtribune
MEI Pharma Inc $MEIP Receives Consensus Recommendation of “Buy” from Analysts https://t.co/AZ1hT6uUTH
June 16th 2019, 2:06am
AmericanBanking @AmericanBanking
MEI Pharma Inc $MEIP Given Consensus Rating of “Buy” by Brokerages https://t.co/KYb9bg6zQj #stocks
June 16th 2019, 2:06am
dispatchtribune @dispatchtribune
Brokerages Expect MEI Pharma Inc $MEIP Will Post Quarterly Sales of $1.05 Million https://t.co/FtFApX2qQn
June 15th 2019, 7:06pm
Gambiste1 @Gambiste1
RT @CostanzTrade: $MEIP 2.55 bounce spot
June 12th 2019, 6:06pm
CostanzTrade @CostanzTrade
$MEIP 2.55 bounce spot
June 12th 2019, 11:06am
OlympiaReport @OlympiaReport
Zacks: Brokerages Anticipate MEI Pharma Inc $MEIP to Announce -$0.20 EPS https://t.co/YRl5VNdSF1
June 11th 2019, 12:06pm
WeekHerald @WeekHerald
$1.05 Million in Sales Expected for MEI Pharma Inc $MEIP This Quarter https://t.co/NARklIlZaC
June 11th 2019, 12:06pm
stocknewstimes @stocknewstimes
MEI Pharma $MEIP Rating Reiterated by HC Wainwright https://t.co/CB7wZu7ZyE
June 11th 2019, 3:06am
SleekMoneycom @SleekMoneycom
MEI Pharma $MEIP Rating Reiterated by HC Wainwright https://t.co/3FyVOKubHD #investing
June 11th 2019, 3:06am
storminvestor @storminvestor
MEI Pharma $MEIP Rating Reiterated by HC Wainwright https://t.co/kJG5YlS1mb #markets
June 11th 2019, 3:06am
buffettvalue @buffettvalue
My position in $MEIP is getting hit. Need to see what is going on with it tonight or if just volatility. Bought a… https://t.co/NdmX72nZPl
June 10th 2019, 5:06pm
MrHypeMind @MrHypeMind
Big volume today.. $MEIP something going on?
June 10th 2019, 3:06pm
bbnsnews @bbnsnews
MEI Pharma’s $MEIP Buy Rating Reaffirmed at HC Wainwright https://t.co/BHEM40e8HD
June 10th 2019, 4:06am
TranscriptDaily @TranscriptDaily
HC Wainwright Reaffirms “Buy” Rating for MEI Pharma $MEIP https://t.co/z63kotPJGJ
June 9th 2019, 8:06am
dailypoliticaln @dailypoliticaln
MEI Pharma $MEIP Stock Rating Reaffirmed by HC Wainwright https://t.co/9Ctv0bQKJ5
June 8th 2019, 9:06am
dailypoliticaln @dailypoliticaln
MEI Pharma Inc $MEIP Expected to Post Quarterly Sales of $1.05 Million https://t.co/8MHg61KusC
June 8th 2019, 2:06am
AmericanBanking @AmericanBanking
Brokerages Expect MEI Pharma Inc $MEIP Will Announce Quarterly Sales of $1.05 Million https://t.co/HmkUfEC76Q #stocks
June 8th 2019, 2:06am
AmericanBanking @AmericanBanking
MEI Pharma’s $MEIP Buy Rating Reaffirmed at HC Wainwright https://t.co/dS2Yv803VN #stocks
June 7th 2019, 10:06am
StockWatchHQ @StockWatchHQ
RT @StockWatchHQ: MEI Pharma $MEIP To Be Purchased By Celgene Corp. $CELG in Stock and Cash Transaction, Announcement Pending https://t.co/…
June 6th 2019, 4:06pm
macondailynews @macondailynews
-$0.20 Earnings Per Share Expected for MEI Pharma Inc $MEIP This Quarter https://t.co/wy9NGIbasM
June 6th 2019, 12:06pm
AmericanBanking @AmericanBanking
MEI Pharma Inc $MEIP Expected to Announce Earnings of -$0.20 Per Share https://t.co/YLQo2XC01l #stocks
June 6th 2019, 12:06pm
StockWatchHQ @StockWatchHQ
MEI Pharma $MEIP To Be Purchased By Celgene Corp. $CELG in Stock and Cash Transaction, Announcement Pending… https://t.co/7aKnsKfBBJ
June 5th 2019, 11:06pm
MrHypeMind @MrHypeMind
@TomSilver39 The is plenty of great news this week about $MEIP, but stock is diving.. weird.
June 5th 2019, 5:06pm
TomSilver39 @TomSilver39
" $MEIP The company recently hired the physician who ran the global registration trials for Bayer’s PI3K inhibitor… https://t.co/qTPDpxLF6a
June 5th 2019, 3:06pm
TomSilver39 @TomSilver39
WF:" believes that $MEIP single agent ME-401 data in 3rd line ALL are as good as high-cost REVLIMID/RITUXAN combina… https://t.co/2we2dJzRco
June 5th 2019, 3:06pm
MrHypeMind @MrHypeMind
Any more news this week? $MEIP
June 4th 2019, 8:06pm
RobinDavison2 @RobinDavison2
RT @TomSilver39: $meip #ASCO19 Poster; Results of the PI3K? Inhibitor ME-401 Alone or with Rituximab in Relapsed/Refractory (R/R) Follicul…
June 4th 2019, 8:06am
fintel_io @fintel_io
Also, if you are new to $MEIP here's some background for you https://t.co/GuAJLS2FiQ
June 3rd 2019, 4:06pm
fintel_io @fintel_io
$MEIP / MEI Pharma files form 8-K https://t.co/hKCqD4tPeN - Financial Statements and Exhibits, Other Events
June 3rd 2019, 4:06pm
Stock_News_Now @Stock_News_Now
$MEIP: New SEC Filing for MEIP: Form 8-K (No. 0001193125-19-164088): https://t.co/RumNNe0dnm
June 3rd 2019, 4:06pm
TomSilver39 @TomSilver39
$meip #ASCO19 Poster; Results of the PI3K? Inhibitor ME-401 Alone or with Rituximab in Relapsed/Refractory (R/R) F… https://t.co/LKhZ8zWb5L
June 3rd 2019, 11:06am
StockNewsNow @StockNewsNow
$MEIP MEI Pharma Presents Updated Clinical Data from the ME-401 Monotherapy and in Combination with Rituximab Phase… https://t.co/ujY23BUc6H
June 3rd 2019, 11:06am
Briefingcom @Briefingcom
$MEIP: MEI Pharma: Updated data from Phase 1b study of investigational ME-401 demonstrate an 80% overall response... https://t.co/vvwr3AeMyv
June 3rd 2019, 11:06am
NewsToDesk @NewsToDesk
$MEIP: MEI Pharma Presents Updated Clinical Data from the ME-401 …: https://t.co/K1nCnmaYoL
June 3rd 2019, 9:06am
DZalkowitz @DZalkowitz
$MEIP good data; way too cheap
June 3rd 2019, 9:06am
BioStocks @BioStocks
$MEIP Presents Updated Clinical Data from the ME-401 Monotherapy and in Combination with Rituximab Phase 1b study i… https://t.co/8O365DecDK
June 3rd 2019, 9:06am
iluvstocks1 @iluvstocks1
$MEIP : MEI Pharma Presents Updated Clinical Data from the ME-401 Monotherapy and in Combination with Rituximab P… https://t.co/Kk64PZppQl
June 3rd 2019, 9:06am
Briefingcom @Briefingcom
$MEIP: MEI Pharma presents data from investigator-initiated study of investigational ME-344 in combination with... https://t.co/aPTawI9U2q
June 3rd 2019, 8:06am
HottestStockNow @HottestStockNow
$MEIP Reveals Clinical Findings for Combo ME-344 + Bevacizumab in Early HER2 Negative Breast Cancer Patients https://t.co/tqa2dEuWIw
June 2nd 2019, 5:06pm
HottestStockNow @HottestStockNow
$MEIP to Present a Corporate Overview at Upcoming Conference https://t.co/tqa2dEuWIw
June 2nd 2019, 5:06pm
damnitfeelsgood @damnitfeelsgood
RT @ToothFrank: $MEIP MEI Pharma Presents Clinical Results for ME-344 in Combination with Bevacizumab in Early HER2 Negative Breast Cancer…
June 2nd 2019, 3:06am
ToothFrank @ToothFrank
$MEIP MEI Pharma Presents Clinical Results for ME-344 in Combination with Bevacizumab in Early HER2 Negative Breast… https://t.co/X2N6Aqew3u
June 2nd 2019, 2:06am
TomSilver39 @TomSilver39
$MEIP #ASCO19 Poster: ME-344 in Combination with Bevacizumab in Early HER2 Negative Breast Cancer https://t.co/7mCn3R0H7l
June 1st 2019, 8:06pm
1stOncology @1stOncology
#MEI Pharma to Present at the Jefferies 2019 Global #HealthcareConference $MEIP https://t.co/pQ7L31RYJE
June 1st 2019, 4:06am
StockNewsNow @StockNewsNow
$MEIP MEI Pharma to Present at the Jefferies 2019 Global Healthcare Conference https://t.co/W4gNaRXwFv
May 31st 2019, 11:05am
TheMarketsDaily @TheMarketsDaily
MEI Pharma Inc $MEIP Given Average Recommendation of “Buy” by Analysts https://t.co/pM4OJPMCgn
May 29th 2019, 2:05pm
dakotafinancial @dakotafinancial
MEI Pharma Inc $MEIP Given Consensus Recommendation of “Buy” by Brokerages https://t.co/lG8f8Lgobu
May 27th 2019, 12:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.